Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

VentriPoint Diagnostics Ltd V.VPT

Alternate Symbol(s):  VPTDF

Ventripoint Diagnostics Ltd. is a Canada-based medical device company. It is engaged in the development and commercialization of diagnostic tools to monitor patients with heart disease. It develops a suite of applications for all heart diseases and imaging modalities, including congenital heart disease, pregnancy, pulmonary hypertension, COVID-19, technically difficult imaging and cardiotoxicity in oncology patients. It provides application of artificial intelligence to echocardiography. Its flagship product, Ventripoint Medical System (VMS+), enhances echocardiography to deliver cMRI levels of accuracy for volumetric measurements and ejection fractions for all four chambers of the heart. It has developed a solution that transforms cardiac care through its 3D ECHO and MRI software. VMS products are powered by its proprietary Knowledge Based Reconstruction technology, which is the result of a decade of development and provides accurate volumetric cardiac measurements equivalent to MRI.


TSXV:VPT - Post by User

Comment by G1945Von Sep 16, 2022 5:31am
79 Views
Post# 34966190

RE:RE:RE:RE:RE:RE:RE:RE:4D is what we were waiting 🚀🚀$$$

RE:RE:RE:RE:RE:RE:RE:RE:4D is what we were waiting 🚀🚀$$$
GrahamB wrote: Actually, in the reference that I have given, there is no statistical difference between the two modalities, using a students tea test at a P value of. 05-
in other words any difference is entirely due to chance.

Bottom line, it looks like , IMO,GE does have a competitive product in some areas, are developing artificial intelligence actively, and there is no evidence yet that VPT had been integrated after over a year.

No sales-zero-on published financials.

When will sales come?

Can you state a date when sales will happen?

(So far no one has been right)







Graham, you continue to pretend to believe that VPT has no viability at all!


G1945V

<< Previous
Bullboard Posts
Next >>